Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Adamo

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Expert Review of Vaccines|May 29, 2014
Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectivesRoberto Adamo
Accounts of Chemical Research|June 28, 2017
Correction to "Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines"Roberto Adamo
Cell Chemical Biology|September 24, 2016
Vaccinology Gets Help from ChemistryRoberto Adamo
Glycoconjugate Journal|July 21, 2021
Broadening the concept of glycoconjugates: glycoRNA and ubiquitinylated lipopolysaccharideRoberto Adamo
Accounts of Chemical Research|May 3, 2017
Advancing Homogeneous Antimicrobial Glycoconjugate VaccinesRoberto Adamo
Glycoconjugate Journal|June 25, 2021
Glycoconjugate vaccines: classic and novel approachesRoberto Adamo
Chemical Society Reviews|October 3, 2018
Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modificationFrancesco Berti, Roberto Adamo
Glycoconjugate Journal|June 7, 2020
Impact of glycoscience in fighting Covid-19Roberto Adamo, Sandro Sonnino
ACS Chemical Biology|July 12, 2013
Recent mechanistic insights on glycoconjugate vaccines and future perspectivesFrancesco Berti, Roberto Adamo
Drug Discovery Today. Technologies|January 3, 2021
Structure-based glycoconjugate vaccine design: The example of Group B Streptococcus type III capsular polysaccharideFilippo Carboni, Roberto Adamo
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Expert Review of Vaccines|May 29, 2014
Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectivesRoberto Adamo
Accounts of Chemical Research|June 28, 2017
Correction to "Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines"Roberto Adamo
Cell Chemical Biology|September 24, 2016
Vaccinology Gets Help from ChemistryRoberto Adamo
Glycoconjugate Journal|July 21, 2021
Broadening the concept of glycoconjugates: glycoRNA and ubiquitinylated lipopolysaccharideRoberto Adamo
Accounts of Chemical Research|May 3, 2017
Advancing Homogeneous Antimicrobial Glycoconjugate VaccinesRoberto Adamo
Glycoconjugate Journal|June 25, 2021
Glycoconjugate vaccines: classic and novel approachesRoberto Adamo
Chemical Society Reviews|October 3, 2018
Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modificationFrancesco Berti, Roberto Adamo
Glycoconjugate Journal|June 7, 2020
Impact of glycoscience in fighting Covid-19Roberto Adamo, Sandro Sonnino
ACS Chemical Biology|July 12, 2013
Recent mechanistic insights on glycoconjugate vaccines and future perspectivesFrancesco Berti, Roberto Adamo
Drug Discovery Today. Technologies|January 3, 2021
Structure-based glycoconjugate vaccine design: The example of Group B Streptococcus type III capsular polysaccharideFilippo Carboni, Roberto Adamo
Pageof 10